Another offering for Avidity; Galera shuts down

Plus, news about Kezar Life Sciences, Elicio Therapeutics and Viracta Therapeutics:

Avidity seeks $250M in public offering: The money will be used in part to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Increase in sedentary time from childhood causes progressing heart enlargement, new study shows

A recent study investigated whether sedentary time (ST), light-intensity physical activity (LPA), and moderate-to-vigorous-intensity physical activity (MVPA) during childhood and young adulthood influence cardiac structure

May 9, 2024

Viromed Medical AG reaches important milestone – agreement with CORIUS Group for exclusive use of Plasma Care® by Viromed with significant growth potential – Biotech Investments

EQS-News: Viromed Medical AG / Key word(s): Alliance Viromed Medical AG reaches important milestone – agreement with CORIUS Group for exclusive use of Plasma Care®

April 23, 2024

FDA Advisory Panel Generally Pleased With Pulse Oximetry Clinical Trial Proposal

An FDA advisory committee gave generally high marks to the agency’s latest effort to improve the accuracy of pulse oximeters when used in darker-skinned patients,

February 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.